학술논문
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
Document Type
Report
Author
Source
Journal of Thrombosis & Thrombolysis; Apr2017, Vol. 43 Issue 3, p306-317, 12p
Subject
Language
ISSN
09295305
Abstract
Copyright of Journal of Thrombosis & Thrombolysis is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)